Immunomodulatory effects of ornithine α-ketoglutarate in rats with burn injuries

Archives of Surgery

Volumn 131, Issue 7, 1996, Pages 718-723

  Roch Arveiller, Monique ^a,c   Tissot, Michèle ^a   Coudray Lucas, Colette ^b   Fontagné, Jeanine ^a   Le Boucher, Jacques ^b   Giroud, Jean Paul ^a   Cynober, Luc ^b  

^a CNRS   (France)

^b INSERM   (France)

^c Pharmacologie ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; AMINO ACID; ARGININE; GLUTAMINE; GLYCINE; ORNITHINE OXOGLUTARATE; PROSTAGLANDIN E2; SUPEROXIDE; ZYMOSAN;

AEROBIC METABOLISM; AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BURN; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENTERIC FEEDING; IMMUNOMODULATION; LEUKOCYTE; MALE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; THYMUS;

EID: 0029951239     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430190040011     Document Type: Article

References (44)

1. Caldwell FT, Wallace BH, Cone JB, Manuel L. Control of the hypermetabolic response to burn injury using environmental factors. Ann Surg. 1992;215:485-491.
2. Newsholme EA, Parry-Billings M. Properties of glutamine release from muscle and its importance for the immune system. J Parent Enter Nutr. 1990;14 (suppl):63S-67S.
3. Calder PC. Glutamine and the immune system. Clin Nutr. 1994;13:2-8.
4. Stehle P, Mertes N, Puchstein CH, et al. Effect of parenteral glutamine peptide supplements on muscle glutamine loss and nitrogen balance after major surgery. Lancet. 1989;1:231-233.
5. Alverdy JC. Effects of glutamine-supplemented diets on immunology of the gut. J Parent Enter Nutr. 1990;(suppl)14:109S-113S.
6. Barbul A. Arginine and immune function. Nutrition. 1990;6:53-58.
7. Alexander JW, Peck MO. Future prospects for adjunctive therapy: pharmacology and nutritional approaches to immune system modulation, Crit Care Med. 1990;18:S159-S164.
8. Leander U, Fürst P, Vesterberg K, Vinnars E. Nitrogen-sparing effect of Ornicetil in the immediate postoperative state, I: clinical biochemistry and nitrogen balance. Clin Nutr. 1985;4:43-51.
9. Cynober L, Saizy R, Nguyen DF, Lioret N, Giboudeau J. Effect of enterally administered ornithine α-ketoglutarate on plasma and urinary amino acid levels after burn injury. J Trauma. 1984;24:590-596.
10. Cynober L, Blondé F, Lioret N, Coudray-Lucas C, Saizy R, Giboudeau J. Arteriovenous differences in amino acids, glucose, lactate and fatty acids in burn patients: effect of ornithine alpha-ketoglutarate. Clin Nutr. 1986;5:221-226.
11. Cynober L, Coudray-Lucas C. A rationale for ornithine alpha-ketoglutarate administration in surgical and trauma patients. In: Latifi R, ed. Amino Acids in Critical Care and Cancer. Austin, Tex: RG Landes Co; 1994:88-96.
12. Coudray-Lucas C, Vaubourdolle M, Ziegler F, et al. Efficacité comparée de l'α-cétoglutarate d'ornithine (ACO) et de la glutamine (Gln) chez le rat brûlé. Gastroenterol Clin Biol. 1990;14:383-384.
13. De Bandt JP, Cynober L, Lim SK, Coudray-Lucas C, Poupon R, Giboudeau J. Metabolism of ornithine, α-ketoglutarate and arginine in isolated perfused rat liver. Br J Nutr. 1995;73:227-239.
14. Le Boucher J, Coudray-Lucas C, Lasnier E, Jardel A, Ekindjian OG, Cynober L. Enterai administration of ornithine alpha-ketoglutarate or arginine alpha-ketoglutarate in burn injury: a comparative study of their effects on glutamine pools in burn-injured rats. Crit Care Med. In press.
15. Bjerkness R, Vindenes H, Pitkanen S, Ninnemannn J, Laerum OD, Abyholm F. Altered polymorphonuclear neutrophilic granulocytic functions in patients with large burns. J Trauma. 1989;29:847-855.
16. Roch-Arveiller M, Fontagné J. Modifications des défenses de l'organisme au cours de la brûlure. Med Sci. 1990;7(suppl):64-68.
17. Goodwin JS, Webb DR. Regulation of the immune responses by prostaglandins. Clin Immunol Immunopathol. 1980;15:106-122.
18. Parry-Billings M, Evans J, Calder PC, Newsholme EA. Does glutamine contribute to immunosuppression after major burns? Lancet. 1990;336:523-525.
19. Walker HL, Mason AD. A standard animal burn? J Trauma. 1968;8:1049-1051.
20. Tissot M, Pham Huy D, Roch-Arveiller M, Mathieu J, Giroud JP. Eicosanoid release and early changes in two acute nonspecific inflammatory reactions: major role of prostacyclin and leucotrienes. Prostaglandins Leukot Essent Fatty Acids. 1991;42:7-14.
21. Johnson R, Kell BB, Misra HP, et al. The role of superoxide anion generation in phagocytic bactericidal activity. J Clin Invest. 1975;55:1357-1372.
22. Van Gelder BF, Slater EC. The extinction coefficient of cytochrome C. Biochem Biophys Acta. 1962;58:593-595.
23. Allen RC, Sternholm L, Steel RH. Evidence for the generation of an electronic state in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun. 1972;47:679-684.
24. Vaubourdolle M, Coudray-Lucas C, Jardel A, Ziegler F, Ekindjian OG, Cynober L. Action of enterally-administered omithine α-ketogluturate on protein breakdown in skeletal muscle and liver of the burned rats. J Parent Enter Nutr. 1991; 15:517-520.
25. Souba WW. Glutamine: Physiology, Biochemistry, and Nutrition in Critical Illness: Interorgan Glutamine Metabolism During Severe Infection. Austin, Tex: RG Landes Co; 1992:79-85.
26. Cynober L, Lioret N, Coudray-Lucas C, et al. Action of ornithine alpha-ketoglutarate on protein metabolism in burn patients. Nutrition. 1987;3:187-191.
27. Donati L, Signorini M, Grappolmi S. Ornithine α-ketoglutarate administration in burn injury. Clin Nutr. 1993;12:70-71.
28. Le Bever M, Coudray-Lucas C, Carsin M, De Bandt JP, Cynober L. Action de l'α-cétoglutarate d'ornithine chez le brûlé: résultats d'une étude prospective, contrôlée, randomisée, en double aveugle contre groupe isoazoté. Nutr Clin Metabol. 1993;7(suppl):33.
29. Bouchon Y, Merle M. L'α-cétoglutarate d'ornithine per os dans la prévention des complications locales de la chirurgie plastique. Ann Chir Plast Esthet. 1984; 29:385-388.
30. Cynober L. Amino acid metabolism in thermal burns. J Parent Enter Nutr. 1989; 13:196-205.
31. Lasnier E, Le Boucher J, Jardel A, Ekindjian OG, Cynober L, Coudray-Lucas C. Efficacité de l'α-cétoglutarate d'ornithine (ACO) chez le rat endotoxémique. Nutr Clin Metabol. 1992;6(suppl):44.
32. Barbul A, Wasserkrug HL, Seifter E, Efron G. Immunostimulatory effects of arginine in normal and injured rats. J Surg Res. 1980;29:228-235.
33. Zapata-Sirvent RL, Hansbrough JF. Temporal analysis of human leucocyte surface antigen expression and neutrophil respiratory burst activity after thermal injury. Burns. 1993;19:5-11.
34. Wernerman J, Hammarqvist H, Ali MR, Vinnars E. Glutamine and ornithine α-ketoglutarate but not branched-chain amino acids reduce the loss of muscle glutamine after surgical trauma. Metabolism. 1989;38(suppl):63-66.
35. Daly JM, Reynolds J, Thom A, et al. Immune and metabolic effects of arginine in the surgical patients. Ann Surg. 1988;208:512-523.
36. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
37. Albina JE, Mills CD, Barbul A, et al. Arginine metabolism in wounds. Am J Physiol. 1988;254:E459-E467.
38. Ardawi MSM, Newsholme EA. Metabolism in lymphocytes and its importance in the immune response. Assay Biochem. 1985;21:1-44.
39. 2's effect on T lymphocyte activation. J Clin Invest. 1987;80:333-340.
40. Goodwin JS. Are prostaglandins proinflammatory, antiinflammatory, both or neither? J Rheumatol. 1991;18(suppl):26-29.
41. Phipps RP, Stein SH, Roper RL. A new view of prostaglandin E regulation of the immune response, Immunol Today. 1991;12:349-352.
42. Dong YL, Herndon DN, Yan TZ, Waymack JP. Blockade of prostaglandin products augments macrophage and neutrophil tumor necrosis factor synthesis in burn injury. J Surg Res. 1993;54:480-485.
43. Salvemini D, Misko TP, Masferrer J, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A. 1993;90: 7240-7244.
44. Salvemini D, Seibert K, Masferrer J, Misko T, Currie MG, Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest. 1994;3:1940-1947.